Kaposi's sarcoma following allogeneic bone marrow transplantation

Area of Science:

• Hematology
• Oncology
• Immunology

Background:

• Allogeneic bone marrow transplantation (BMT) can lead to severe immunosuppression.
• Kaposi's sarcoma (KS) is a rare malignancy, particularly post-BMT.
• Genetic predisposition may influence KS development.

Observation:

• A patient with genetic predisposition developed localized Kaposi's sarcoma 240 days post-allogeneic BMT.
• The patient was severely immunosuppressed and HIV-negative.
• Tumor origin was confirmed as host-derived using DNA minisatellite analysis.

Findings:

• Radiotherapy led to near-complete regression of Kaposi's sarcoma lesions.
• The patient ultimately succumbed to relapsed acute myelogenous leukemia.
• Kaposi's sarcoma development after BMT is exceptionally rare, unlike after organ allografts.

Implications:

• This case highlights a rare instance of Kaposi's sarcoma post-allogeneic BMT.
• Host-derived tumor origin in KS post-BMT warrants further investigation.
• Understanding immunosuppression and genetic factors is crucial in BMT complications.